39891-08-2 Usage
General Description
(5-Bromo-pyridin-3-yl)-acetonitrile is a chemical compound with the molecular formula C7H5BrN2. It is a derivative of pyridine with a bromine atom and a nitrile group attached to the third carbon of the pyridine ring. This chemical is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is also used as an intermediate in the production of various chemical products. The presence of the bromine atom and the nitrile group provides unique reactivity and properties to this compound, making it valuable for various industrial and research applications.
Check Digit Verification of cas no
The CAS Registry Mumber 39891-08-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,8,9 and 1 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 39891-08:
(7*3)+(6*9)+(5*8)+(4*9)+(3*1)+(2*0)+(1*8)=162
162 % 10 = 2
So 39891-08-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H5BrN2/c8-7-3-6(1-2-9)4-10-5-7/h3-5H,1H2
39891-08-2Relevant articles and documents
Novel 2,4-disubstituted pyrimidines as potent, selective, and cell-permeable inhibitors of neuronal nitric oxide synthase
Mukherjee, Paramita,Li, Huiying,Sevrioukova, Irina,Chreifi, Georges,Martásek, Pavel,Roman, Linda J.,Poulos, Thomas L.,Silverman, Richard B.
, p. 1067 - 1088 (2015/03/04)
Selective inhibition of neuronal nitric oxide synthase (nNOS) is an important therapeutic approach to target neurodegenerative disorders. However, the majority of the nNOS inhibitors developed are arginine mimetics and, therefore, suffer from poor bioavai
QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
-
Page/Page column 287, (2011/04/14)
A compound of formula (I) wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
